The next generation of life sciences audit


Audit evolved

The next generation of life sciences audit

​Running a life sciences business has never been more challenging. Life sciences (LS) companies face pricing pressures as health care reform puts a laser focus on patient outcomes and measurable results. Is the complex mix of market forces a major threat or an opportunity? At Deloitte, we see it as part of the evolution of life sciences—and we are evolving with it.

Download the brochure

The life sciences brochure will provide you with:

  • An overview of disruptive industry forces and issues
  • Statistics on Deloitte’s LS industry team and practice
  • Audit as an opportunity, innovation, and more

Disrupting the norm

Powerful market forces in life sciences are influencing how companies compete and grow. Six key trends appear to be shaping the industry.

​Audit evolved. At Deloitte, audit is more than an obligation for our clients—it’s an opportunity.

The services described herein are illustrative in nature and are intended to demonstrate our experience and capabilities in these areas; however, due to independence restrictions that may apply to audit clients (including affiliates) of Deloitte & Touche LLP, we may be unable to provide certain services based on individual facts and circumstances.

Did you find this useful?